{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T18:43:43Z","timestamp":1720205023658},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.toxlet.2016.06.1681","type":"journal-article","created":{"date-parts":[[2016,9,8]],"date-time":"2016-09-08T01:47:30Z","timestamp":1473299250000},"page":"S184-S185","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S","title":["1-(Propan-2-ylamino)-4-propoxy-9h-thioxanthen-9-one (TX5), a newly synthetized P-glycoprotein activator: In vivo study and method development and validation for biological samples quantification"],"prefix":"10.1016","volume":"258","author":[{"given":"A.","family":"Ferreira","sequence":"first","affiliation":[]},{"given":"F.","family":"Ponte","sequence":"additional","affiliation":[]},{"given":"R.","family":"Silva","sequence":"additional","affiliation":[]},{"given":"C.R.","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"E.","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"M.","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"M.","family":"Bastos","sequence":"additional","affiliation":[]},{"given":"F.","family":"Remi\u00e3o","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427416318318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427416318318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T19:25:25Z","timestamp":1536434725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427416318318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":0,"alternative-id":["S0378427416318318"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2016.06.1681","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1-(Propan-2-ylamino)-4-propoxy-9h-thioxanthen-9-one (TX5), a newly synthetized P-glycoprotein activator: In vivo study and method development and validation for biological samples quantification","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2016.06.1681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}